期刊文献+

多靶点药物治疗及药物发现 被引量:30

Multi-target therapeutics and new drug discovery
原文传递
导出
摘要 作用于单靶点的药物在治疗复杂性疾病如肿瘤、糖尿病、感染性疾病时常常疗效不佳或毒性较大。多靶点药物可以同时调节疾病网络系统中的多个环节,不易产生抗药性,对各靶点的作用产生协同效应,达到最佳的治疗效果。本文对多靶点药物治疗的特点、分类情况、发现策略、筛选模型及已在临床使用的多靶点治疗药物进行综述,并探讨中药在多靶点药物治疗应用中的潜力。 Drugs acting on individual molecular targets usually exert unsatisfying therapeutic effects or have severe toxicity when used in diseases of complicated causes such as tumor, diabetes and inflammation. Multi-target therapeutics which regulates multiple nodes of the disease network simultaneously shows synergistic effect, is unlikely to induce resistance and provides optimal clinical use. This review summarized the characteristics, classification, development strategies and screening models, current multi-target therapeutic drugs used in clinic and also explored the potential of TCM in multi-target therapeutics.
作者 徐炎 李学军
出处 《药学学报》 CAS CSCD 北大核心 2009年第3期226-230,共5页 Acta Pharmaceutica Sinica
关键词 多靶点 联合用药 多组分药物 协同作用 multi-target multidrug combination multicomponent drug synergistic effect
  • 相关文献

参考文献23

  • 1Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? [J]. Nat Rev Drug Discov, 2004, 3: 711-716.
  • 2Bolognesi ML, Cavalli A, Melchiorre C. Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease [J]. Neurotherapeutics, 2009, 6: 152-162.
  • 3Pollio G, Roncarati R, Seredenina T, et al. A reporter assay for target validation in primary neuronal cultures [J]. J Neurosci Meth, 2008, 172: 34-37.
  • 4Schrattenholz A, Soskic V. What does systems biology mean for drug development? [J]. Curr Med Chem, 2008, 15: 1520- 1528.
  • 5Zimmermann GR, Lehar J, Keith CT. Multi-target therapeutics: when the whole is greater than the sum of the parts [J]. Drug Discov Today, 2007, 12: 34-42.
  • 6Gupta GP, Nguyen DX, Chiang AC, et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis [J]. Nature, 2007, 446: 765-770.
  • 7Zent CS. The role of alemtuzumab in the treatment of chronic lymphocytic leukemia [J]. Leuk Lymphoma, 2008, 49: 175-176.
  • 8Hopkins AL. Network pharmacology: the next paradigm in drug discovery [J]. Nat Chem Biol, 2008, 4: 682-690.
  • 9Petrelli A, Giordano S. From single- to multi-target drugs in cancer therapy: when a specificity becomes an advantage [J]. Curr Med Chem, 2008, 15: 422-432.
  • 10Mayer T, Jagla B, Wyler MR, et al. Cell based assays using primary endothelial cells to study multiple steps in inflammation [J]. Method Enzymol, 2006, 414: 266-283.

同被引文献402

引证文献30

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部